Gland Pharma Limited (GLAND) — Announcement

· NSE Neutral
📢 Key Event
Gland Pharma announces investor meeting schedule
💡 Investor Takeaway
Investors can engage directly with management through scheduled one-on-one meetings.

Gland Pharma announced a schedule of analyst and institutional investor meetings, including a one-on-one session with SiMPL PMS on June 22, 2026, arranged by Kotak Securities. The notice emphasizes that the schedule may change due to operational exigencies and serves as an informational update for stakeholders. This event provides investors with direct engagement opportunities with company management ahead of potential market-moving discussions.

📄 View Original Announcement (PDF)

About Gland Pharma Limited (GLAND)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹30,781.44 Cr P/E: 43.7

View full GLAND stock details →

📡 Get AI alerts when GLAND files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GLAND — Free

📊 More GLAND filings

See all GLAND filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when GLAND files new disclosures

Track GLAND filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track GLAND — Free

Free account · 2 AI queries/day